Taxol Carboplatin Adjuvant Breast Cancer Her-2 Negative

Featured Health Expert
87_4803
EXPERT

All HER2 Positive Breast Cancers Should Get Adjuvant Chemotherapy and Herceptin

From the San Antonio Breast Conference in December, new data shows a higher than predicted rate of breast cancer recurrence even with very small breast cancers that are HER2 positive. The data is from the first large study to analyze early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller. All these women would benefit from adjuvant Trastuzumab, also known as Herceptin, (for one year, the standard in America) - along with adjuvant chemotherapy. This represents a...

Read more

More information on "Taxol Carboplatin Adjuvant Breast Cancer Her-2 Negative"

From Our Experts

See more SharePosts »

From Our Sources

More on Breast Cancer »